Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Baxter
Johnson and Johnson
Moodys
AstraZeneca

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Pliva Hrvatska Doo Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PLIVA HRVATSKA DOO, and what generic and branded alternatives to PLIVA HRVATSKA DOO drugs are available?

PLIVA HRVATSKA DOO has eight approved drugs.

There are four tentative approvals on PLIVA HRVATSKA DOO drugs.

Summary for Pliva Hrvatska Doo
US Patents:0
Tradenames:7
Ingredients:7
NDAs:8
Drug Master File Entries: 1

Drugs and US Patents for Pliva Hrvatska Doo

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva Hrvatska Doo TOPIRAMATE topiramate TABLET;ORAL 077905-003 Mar 30, 2009 DISCN No No   Start Trial   Start Trial
Pliva Hrvatska Doo CARVEDILOL carvedilol TABLET;ORAL 078240-004 Oct 30, 2007 DISCN No No   Start Trial   Start Trial
Pliva Hrvatska Doo CARVEDILOL carvedilol TABLET;ORAL 078240-002 Oct 30, 2007 DISCN No No   Start Trial   Start Trial
Pliva Hrvatska Doo PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077730-001 Nov 21, 2006 DISCN No No   Start Trial   Start Trial
Pliva Hrvatska Doo CILOSTAZOL cilostazol TABLET;ORAL 077898-001 Oct 29, 2007 DISCN No No   Start Trial   Start Trial
Pliva Hrvatska Doo CARVEDILOL carvedilol TABLET;ORAL 078240-001 Oct 30, 2007 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Moodys
Dow
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.